Guided by these results, we proceeded to a mechanistic study that ultimately uncovered a dual IFN‐dependent repressive role of BO‐110 on tumor cells (inhibiting MDK expression and secretion) and on lymphatic endothelial cells (repressing on Vegfr3 mRNA levels). The gene discussed is FLT4; the disease is neoplasm.